VASINFRA stock news
This page provides real-time market news, earnings updates, and company announcements related to Vas Infrastructure Limited (VASINFRA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-20 14:50 IST
Visa’s Growth in Blockchain and AI Drives Earnings Above Expectations, Offsetting Competition from Emerging Challengers
Bitget-RWA2025-10-29 05:18:14
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats
Bitget-RWA2025-11-23 20:30:10
Novartis expects to eliminate US tariff exposure by mid‑2026, CEO tells CNBC
101 finance2026-01-20 10:21:32
Novartis faces generic drug competition during its transformation pains, expects profits to decline this year
格隆汇2026-02-04 06:24:34
Payments Power Play: MA or AXP, Who Has the Deeper Moat in 2026?
Finviz2026-02-18 16:21:50
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Finviz2026-02-28 07:24:44
Is Visa Inc. (V) A Good Stock To Buy Now?
Finviz2026-03-04 23:00:53
Visa Doubles Down on Stablecoins: Is This the Key to Securing Its Network’s Future?
101 finance2026-03-12 16:49:00
Explosive Growth! Morgan Stanley: China's AI Cloud Market CAGR Will Reach 72% in Five Years, Alibaba Expected to Be the Biggest Winner
华尔街见闻2026-03-17 08:58:09
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Finviz2026-03-18 11:03:57
Weibo Corp's AI Timeline Shifts and Ad Revenue Outlook Diverge in 2025 Q4 Earnings Call
101 finance2026-03-18 13:12:40
Novartis's Atrium SpinCo: A Bold Cardiovascular Bet with Significant Risk and Reward Potential
101 finance2026-03-19 18:31:02
Novartis’s $3B PI3Kα Purchase: Strategic Investment in Targeted Cancer Therapy as Patent Protection Nears End
101 finance2026-03-20 07:06:38
Payments Power Play: MA or AXP, Who Has the Deeper Moat in 2026?
Finviz2026-02-18 16:21:50
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Finviz2026-02-28 07:24:44
Is Visa Inc. (V) A Good Stock To Buy Now?
Finviz2026-03-04 23:00:53
Visa Doubles Down on Stablecoins: Is This the Key to Securing Its Network’s Future?
101 finance2026-03-12 16:49:00
Explosive Growth! Morgan Stanley: China's AI Cloud Market CAGR Will Reach 72% in Five Years, Alibaba Expected to Be the Biggest Winner
华尔街见闻2026-03-17 08:58:09
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Finviz2026-03-18 11:03:57
Weibo Corp's AI Timeline Shifts and Ad Revenue Outlook Diverge in 2025 Q4 Earnings Call
101 finance2026-03-18 13:12:40
Novartis's Atrium SpinCo: A Bold Cardiovascular Bet with Significant Risk and Reward Potential
101 finance2026-03-19 18:31:02
Novartis’s $3B PI3Kα Purchase: Strategic Investment in Targeted Cancer Therapy as Patent Protection Nears End
101 finance2026-03-20 07:06:38
VASINFRA stock price change
On the last trading day, VASINFRA stock closed at 8.93 INR, with a price change of -5.00% for the day.
Trade stock perpsVASINFRA stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more